Global Cancer Biological Therapy Market 2018 Size, Development Status, Type and Application, Segmentation, Forecast by 2023

WiseGuyReports.com adds “Cancer Biological Therapy Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023”reports to its database.

Pune, India - January 12, 2018 /MarketersMedia/ —

Cancer Biological Therapy Market:

Executive Summary

Biological therapy treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. There are various types of biological therapies, which inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies.

The global cancer biological therapy market is expected to reach USD 82,276.8 million by 2023 at a CAGR of 4.7% during the forecasted period.  

The global cancer biological therapy market is segmented on the basis of phases, types, end users and regions. On the basis of phases, the market is segmented into phase I, phase II and phase III. In stage I & II the real impact of these therapies is seen and giving a success rate of 35% in Phase 1 and 20% in Phase II. The success rate of phase I is 35%.

On the basis on types, the global cancer biological therapy market is segmented into monoclonal antibodies, cancer growth blockers, interferons, interleukins, gene therapy, targeted drug delivery, colony stimulating factor, cancer vaccines and others. Monoclonal antibodies accounted for the largest market share of the global cancer biological therapy market. Colony stimulating factor is the fastest growing market at a CAGR of 5.2% during the forecasted period.

On the basis on end users, hospitals & clinics dominates the global cancer biological therapy market. Registering USD 26,790.6 million in 2016 and expected to reach at USD 38,471.9 million by 2023 at the rate of 4.4 % from 2016-2023. 

On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and the Middle East & Africa. North America has the dominating market for cancer biological therapy. The cancer biological therapy market for North America is estimated at USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%.

Request Sample Report @ https://www.wiseguyreports.com/sample-request/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Key Players

The leading market players in the global cancer biological therapy market include Merck Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Amgen Inc., Bristol-Myers Squibb, Celgene, ELI Lilly and Company, EnGeneIC, and Pfizer

Study objectives

To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global cancer biological therapy market
To provide insights about factors influencing and affecting the market growth
To provide historical and forecast revenue of the market segments and sub-segments with respect to countries
To provide historical and forecast revenue of the market segments based on channels, applications, and regions for the global cancer biological therapy market.
To provide strategic profiling of key players in the market, and comprehensively analysing their market share, core competencies, and drawing a competitive landscape for the market
To provide economical factors that influences the global cancer biological therapy market
To provide detailed analysis of the value chain and supply chain of the global cancer biological therapy market

Target Audience

Pharmaceutical Companies
Pharmaceutical Suppliers
Cancer Research Organizations
Potential Investors
Key Executive (CEO and COO) and Strategy Growth Manager
Reaserch Companies

For further information on this report, visit - https://www.wiseguyreports.com/enquiry/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Key Findings

North America accounted for the largest market share in the global cancer biological therapy market, USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%
Colony stimulating factor is the fastest growing segment with a CAGR of and 5.2% in the global cancer biological therapy market, by types
Hospitals and clinics is contributing remarkable share in the market registering 47.8% in the global cancer biological therapy market, by end users in 2016

The reports also covers regional analysis

North America
o US

o Canada

Europe
o Germany

o France

o U.K.

o Italy

o Spain

o Rest of Europe

Asia Pacific
o Japan

o China

o India

o Republic of Korea

o Rest of Asia-Pacific

Middle East & Africa
o Middle East

o Africa

Continuous…

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1793685

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: Wise Guy Research Consultants Pvt Ltd
Address: Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +1-646-845-9349 (US); +44 208 133 9349 (UK)

Source URL: https://marketersmedia.com/global-cancer-biological-therapy-market-2018-size-development-status-type-and-application-segmentation-forecast-by-2023/286775

For more information, please visit https://www.wiseguyreports.com/reports/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Source: MarketersMedia

Release ID: 286775

Latest News

Puerto Rico moves to privatize troubled power company

Jan 23, 2018

SAN JUAN, Puerto Rico — Puerto Rico's governor announced Monday that he is moving to privatize the U.S. territory's public power company after its slow, troubled recovery from Hurricane Maria focused new attention on longstanding accusations of mismanagement and corruption. Nearly 30 percent of customers on this island of 3.3 million people remain without power more than four months after Hurricane Maria. Many blame the failings of the Puerto Rico Electric Power Authority, or PREPA. Its director was forced out in November after the utility failed to immediately call for help from its mainland counterparts after the storm. Instead, PREPA...

Trump hits solar panels, washing machines with tariffs

Jan 23, 2018

WASHINGTON — President Donald Trump on Monday approved tariffs on imported solar-energy components and large washing machines in a bid to help U.S. manufacturers. The president's decision followed recommendations for tariffs by the U.S. International Trade Commission. "The president's action makes clear again that the Trump administration will always defend American workers, farmers, ranchers, and businesses in this regard," U.S. Trade Representative Robert Lighthizer said in a statement announcing the decision. Most imported solar modules will face an immediate tariff of 30 percent, with the rate declining before phasing out after four years. For large residential washing machines, tariffs will...

Get your stuff and go: Amazon opens store with no cashiers

Jan 23, 2018

SEATTLE — No cashiers, no registers and no cash — this is how Amazon sees the future of store shopping. The online retailer opened its Amazon Go concept to the public Monday in Seattle, which lets shoppers take milk, potato chips or ready-to-eat salads off its shelves and just walk out. Amazon's technology charges customers after they leave. "It's such a weird experience, because you feel like you're stealing when you go out the door," said Lisa Doyle, who visited the shop Monday. Amazon employees have been testing the store, at the bottom floor of the company's Seattle headquarters, for...

Wild ride: 'Jumanji' holds on to top spot at box office

Jan 23, 2018

NEW YORK — "Jumanji: Welcome to the Jungle" notched its third straight weekend on top of the box office, besting a pair of new releases — "12 Strong" and "Den of Thieves" — both of which still managed to slightly outperform expectations. Sony's "Jumanji" took in $19.5 million in ticket sales in its fifth weekend of releases, according to final box-office figures Monday. The reboot, starring Dwayne Johnson and Kevin Hart, has shown surprisingly strong legs after spending its first two weeks of release in second behind "Star Wars: The Last Jedi." Its cumulative total through Sunday is $316.5 million....

Uber driver in US illegally charged with 4 California rapes

Jan 23, 2018

LOS ANGELES — A Mexican man living in the U.S. illegally used his job as an Uber driver to target intoxicated young women and was charged Monday with raping, assaulting and robbing four victims, California prosecutors said. Alfonso Alarcon-Nunez drove women to their homes, assaulted them, and stole property including cellphones, computers and jewelry, officials said. He collected his fare payments through the smartphone app Venmo to disguise his identity and his Uber records. DNA evidence helped lead detectives to Alarcon-Nunez, who was arrested at his Santa Maria home last week, San Luis Obispo County District Attorney Dan Dow said...

Search

Deck Biz is an intelligent platform providing international and regional business news updates. You won’t get these insights elsewhere other than Deck Biz.

Contact us: sales@deckbiz.com